{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:46:23Z","timestamp":1792179983051,"version":"4.4.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011798","name":"Ministry of Agriculture and Rural Affairs of the People's Republic of China","doi-asserted-by":"publisher","award":["NYX2024009"],"award-info":[{"award-number":["NYX2024009"]}],"id":[{"id":"10.13039\/501100011798","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.phymed.2026.157987","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:05:59Z","timestamp":1771358759000},"page":"157987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Isorhamnetin alleviates diet induced MASLD in mice by modulating gut microbiota and bile acid metabolism"],"prefix":"10.1016","volume":"153","author":[{"given":"Yi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aige","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3744-4575","authenticated-orcid":false,"given":"Wenhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.phymed.2026.157987_bib0001","first-page":"Ms6","article-title":"Safety and efficacy of combined ezetimibe\/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease","volume":"15","author":"Abel","year":"2009","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.phymed.2026.157987_bib0002","doi-asserted-by":"crossref","unstructured":"Arab, J.P., Karpen, S.J., Dawson, P.A., Arrese, M., Trauner, M., 2017. Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. 65(1), 350-362.","DOI":"10.1002\/hep.28709"},{"issue":"8","key":"10.1016\/j.phymed.2026.157987_bib0003","article-title":"Evidence from a systematic review of non-alcoholic fatty liver disease (NAFLD)\/metabolic dysfunction-associated fatty liver disease (MASLD) fueling cardiovascular risk","volume":"17","author":"Bhatt","year":"2025","journal-title":"Cureus."},{"issue":"711055","key":"10.1016\/j.phymed.2026.157987_bib0004","article-title":"Procedures for fecal microbiota transplantation in murine microbiome studies","volume":"11","author":"Bokoliya","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.phymed.2026.157987_bib0005","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.phymed.2026.157987_bib0006","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2026.157987_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157552","article-title":"Ginsenoside Rg2 ameliorates metabolic dysfunction-related steatohepatitis via the Nrf2 pathway by suppressing inflammation, apoptosis, oxidative stress and fibrosis","volume":"149","author":"Chen","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0008","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s10020-024-01022-3","article-title":"Bioinformatics based exploration of the anti-NAFLD mechanism of Wang's empirical formula via TLR4\/NF-\u03bab\/COX2 pathway","volume":"30","author":"Chen","year":"2024","journal-title":"Mol. Med. (Camb. Mass,)"},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0009","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00011-015-0887-9","article-title":"Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses","volume":"65","author":"Chi","year":"2016","journal-title":"Inflamm. Res.: Off. J. Eur. Histamine Res. Soc. [et al,]"},{"issue":"8","key":"10.1016\/j.phymed.2026.157987_bib0010","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/acs.molpharmaceut.9b00426","article-title":"Tyrosine phosphorylation regulates plasma membrane expression and stability of the human bile acid transporter ASBT (SLC10A2)","volume":"16","author":"Chothe","year":"2019","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.phymed.2026.157987_bib0011","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1002\/fsn3.3426","article-title":"Antiobesity effects of onion (Allium cepa) in subjects with obesity: systematic review and meta-analysis","volume":"11","author":"Chung","year":"2023","journal-title":"Food Sci. Nutr."},{"issue":"8","key":"10.1016\/j.phymed.2026.157987_bib0012","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2026.157987_bib0013","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ejphar.2014.06.017","article-title":"AMPK activation by isorhamnetin protects hepatocytes against oxidative stress and mitochondrial dysfunction","volume":"740","author":"Dong","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"32","key":"10.1016\/j.phymed.2026.157987_bib0014","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phymed.2026.157987_bib0016","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52736-y","article-title":"Isorhamnetin alleviates steatosis and fibrosis in mice with nonalcoholic steatohepatitis","volume":"9","author":"Ganbold","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2026.157987_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110301","article-title":"Isorhamnetin: a review of pharmacological effects","volume":"128","author":"Gong","year":"2020","journal-title":"Biomed. PharmacOther"},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010299","article-title":"Anti-obesity effects of Isorhamnetin and Isorhamnetin conjugates","volume":"24","author":"Gonz\u00e1lez-Arceo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.phymed.2026.157987_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1564852","article-title":"Novel insights from meta-analysis: the efficacy of ginsenosides in non-alcoholic fatty liver disease","volume":"16","author":"Hao","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.157987_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157515","article-title":"Constituents-composed Chinese medicine of Dajianzhong decoction ameliorates non-alcoholic fatty liver disease via AMPK\/ppar\u03b1\/CPT1 signaling","volume":"149","author":"He","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.157987_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115279","article-title":"Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K\/AKT\/mTOR and HIF-1\/VEGF cascade","volume":"165","author":"He","year":"2023","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2026.157987_bib0024","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4939-2742-5_9","article-title":"The western blot","volume":"1318","author":"Hnasko","year":"2015","journal-title":"Methods Mol. Biol. (Clifton N.J.)"},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13099-024-00632-w","article-title":"Desulfovibrio vulgaris caused gut inflammation and aggravated DSS-induced colitis in C57BL\/6 mice model","volume":"16","author":"Huang","year":"2024","journal-title":"Gut Pathog."},{"issue":"6","key":"10.1016\/j.phymed.2026.157987_bib0026","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cmet.2016.10.001","article-title":"Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion","volume":"24","author":"Jakulj","year":"2016","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.phymed.2026.157987_bib0027","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3892\/ijmm.2015.2074","article-title":"Puerarin ameliorates hepatic steatosis by activating the ppar\u03b1 and AMPK signaling pathways in hepatocytes","volume":"35","author":"Kang","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.phymed.2026.157987_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116046","article-title":"Molecular basis of bile acid-FXR-FGF15\/19 signaling axis","volume":"23","author":"Katafuchi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.phymed.2026.157987_bib0029","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.phymed.2026.157987_bib0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4132\/jptm.2016.08.08","article-title":"Immunohistochemistry for pathologists: protocols, pitfalls, and tips","volume":"50","author":"Kim","year":"2016","journal-title":"J. Pathol. Transl. Med."},{"issue":"2","key":"10.1016\/j.phymed.2026.157987_bib0031","first-page":"682","article-title":"Isorhamnetin alleviates lipopolysaccharide-induced inflammatory responses in BV2 microglia by inactivating NF-\u03bab, blocking the TLR4 pathway and reducing ROS generation","volume":"43","author":"Kim","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"10.1016\/j.phymed.2026.157987_bib0032","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1039\/D4FO04867A","article-title":"Isorhamnetin ameliorates hyperuricemia by regulating uric acid metabolism and alleviates renal inflammation through the PI3K\/AKT\/NF-\u03bab signaling pathway","volume":"16","author":"Kong","year":"2025","journal-title":"Food Funct."},{"issue":"10","key":"10.1016\/j.phymed.2026.157987_bib0033","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.cmet.2023.07.011","article-title":"Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis","volume":"35","author":"Kuang","year":"2023","journal-title":"Cell Metab."},{"issue":"19","key":"10.1016\/j.phymed.2026.157987_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/foods13193076","article-title":"Isorhamnetin in Quinoa whole-grain flavonoids intervenes in non-alcoholic fatty liver disease by modulating bile acid metabolism through regulation of FXR expression","volume":"13","author":"La","year":"2024","journal-title":"Foods."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0035","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0036","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2304159","article-title":"Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism","volume":"16","author":"Li","year":"2024","journal-title":"Gut. Microbes."},{"key":"10.1016\/j.phymed.2026.157987_bib0037","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2147\/JIR.S302934","article-title":"Ginkgo biloba extract 50 (GBE50) ameliorates insulin resistance, hepatic steatosis and liver injury in high fat diet-fed mice","volume":"14","author":"Li","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.phymed.2026.157987_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120197","article-title":"\u03b1-D-1,3-glucan from Radix Puerariae thomsonii improves NAFLD by regulating the intestinal flora and metabolites","volume":"299","author":"Li","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phymed.2026.157987_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.tifs.2025.104944","article-title":"Recent advances in innovative extraction techniques, comprehensive composition analysis, bioactivity assessment, and development of efficient delivery systems for sea buckthorn oil","volume":"159","author":"Li","year":"2025","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.phymed.2026.157987_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1447878","article-title":"Regulation of bile acids and their receptor FXR in metabolic diseases","volume":"11","author":"Li","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.phymed.2026.157987_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156043","article-title":"Comparative efficacy of THR-\u03b2 agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and pan-PPAR agonists for MASLD: a systematic review and network meta-analysis","volume":"161","author":"Lin","year":"2024","journal-title":"Metabolism."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0042","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13578-025-01382-1","article-title":"Special correlation between diet and MASLD: positive or negative?","volume":"15","author":"Liu","year":"2025","journal-title":"Cell Biosci."},{"key":"10.1016\/j.phymed.2026.157987_bib0043","article-title":"Efficacy of flavonoids in non-alcoholic fatty liver disease: an updated systematic review and meta-analysis","volume":"12","author":"Liu","year":"2025","journal-title":"Front. Nutr."},{"issue":"19","key":"10.1016\/j.phymed.2026.157987_bib0044","first-page":"3859","article-title":"[Determination of plasma concentration of quercetin, kaempferid and isorhamnetin in Hippophae rhamnoides extract by HPLC-MS\/MS and pharmacokinetics in rats]","volume":"40","author":"Liu","year":"2015","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J. Chin. Mater. Med."},{"issue":"3","key":"10.1016\/j.phymed.2026.157987_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120259","article-title":"Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K\/AKT activation and HO-1 induction","volume":"10","author":"Luo","year":"2015","journal-title":"PLoS. One"},{"key":"10.1016\/j.phymed.2026.157987_bib0046","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.omtm.2020.11.007","article-title":"qPCR and qRT-PCR analysis: regulatory points to consider when conducting biodistribution and vector shedding studies","volume":"20","author":"Ma","year":"2021","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.phymed.2026.157987_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157517","article-title":"Gut-liver axis mechanisms of Hippophae rhamnoides L. in non-alcoholic fatty liver disease prevention","volume":"149","author":"Ma","year":"2025","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.phymed.2026.157987_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051474","article-title":"The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?","volume":"12","author":"Magne","year":"2020","journal-title":"Nutrients."},{"key":"10.1016\/j.phymed.2026.157987_bib0049","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2025.09.002","article-title":"Bile acids in liver and gastrointestinal cancer","volume":"116","author":"Monte","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.phymed.2026.157987_bib0050","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1017\/S0007114512001213","article-title":"Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia","volume":"108","author":"Moreira","year":"2012","journal-title":"Br. J. Nutr."},{"issue":"7","key":"10.1016\/j.phymed.2026.157987_bib0051","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/metabo12070647","article-title":"Farnesoid X receptor, bile acid metabolism, and gut microbiota","volume":"12","author":"Mori","year":"2022","journal-title":"Metabolites"},{"issue":"11","key":"10.1016\/j.phymed.2026.157987_bib0052","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14852","article-title":"Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight\/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial","volume":"75","author":"Namkhah","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"2","key":"10.1016\/j.phymed.2026.157987_bib0053","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.livres.2019.05.001","article-title":"The acidic pathway of bile acid synthesis: not just an alternative pathway","volume":"3","author":"Pandak","year":"2019","journal-title":"Liver. Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0054","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7762\/cnr.2020.9.1.11","article-title":"Effects of quercetin supplementation on hematological parameters in non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study","volume":"9","author":"Pasdar","year":"2020","journal-title":"Clin. Nutr. Res."},{"issue":"2","key":"10.1016\/j.phymed.2026.157987_bib0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor","volume":"17","author":"Pineda Torra","year":"2003","journal-title":"Mol. Endocrinol. (Baltim. Md.)"},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0056","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12944-025-02474-0","article-title":"Hypothyroidism\/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment","volume":"24","author":"Pu","year":"2025","journal-title":"Lipids Health Dis."},{"issue":"15","key":"10.1016\/j.phymed.2026.157987_bib0057","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157381","article-title":"Isorhamnetin: reviewing recent developments in anticancer mechanisms and nanoformulation-driven delivery","volume":"26","author":"Rana","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.phymed.2026.157987_bib0059","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1039\/C4FO01092B","article-title":"The effect of isorhamnetin glycosides extracted from Opuntia ficus-indica in a mouse model of diet induced obesity","volume":"6","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2015","journal-title":"Food Funct."},{"key":"10.1016\/j.phymed.2026.157987_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112318","article-title":"Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2\/HO-1 pathway and chelating iron","volume":"135","author":"Ru","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.phymed.2026.157987_bib0061","first-page":"561","article-title":"Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers","volume":"55","author":"Schulz","year":"2005","journal-title":"Arzneim.-Forsch."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0062","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40168-024-02004-7","article-title":"Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters","volume":"13","author":"Schwenger","year":"2025","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0063","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/s41598-017-01576-9","article-title":"Gender differences in bile acids and microbiota in relationship with Gender dissimilarity in steatosis induced by diet and FXR inactivation","volume":"7","author":"Sheng","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0064","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12944-022-01754-3","article-title":"Dietary fat induced chylomicron-mediated LPS translocation in a bicameral Caco-2cell model","volume":"22","author":"Tomassen","year":"2023","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0065","first-page":"61","article-title":"Metabolic dysfunction-associated fatty liver disease on distinct microbial communities at the bacterial phylum level","volume":"42","author":"Uojima","year":"2024","journal-title":"Dig. Dis. (Basel Switz.)"},{"issue":"4","key":"10.1016\/j.phymed.2026.157987_bib0066","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8040573","article-title":"The controversial role of Human gut lachnospiraceae","volume":"8","author":"Vacca","year":"2020","journal-title":"Microorganisms."},{"issue":"29","key":"10.1016\/j.phymed.2026.157987_bib0067","doi-asserted-by":"crossref","first-page":"19211","DOI":"10.1074\/jbc.M109.014860","article-title":"Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol","volume":"284","author":"van der Veen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2026.157987_bib0068","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2023.12.010","article-title":"Isorhamnetin alleviates cisplatin-induced acute kidney injury via enhancing fatty acid oxidation","volume":"212","author":"Wang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phymed.2026.157987_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1067813","article-title":"Sea buckthorn pulp and seed oils ameliorate lipid metabolism disorders and modulate gut microbiota in C57BL\/6J mice on high-fat diet","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Nutr."},{"issue":"10","key":"10.1016\/j.phymed.2026.157987_bib0070","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.phymed.2026.157987_bib0071","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41564-023-01418-7","article-title":"Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid","volume":"8","author":"Wei","year":"2023","journal-title":"Nat. Microbiol."},{"issue":"5","key":"10.1016\/j.phymed.2026.157987_bib0072","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114742","article-title":"When fat meets the gut-focus on intestinal lipid handling in metabolic health and disease","volume":"14","author":"Wit","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phymed.2026.157987_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155299","article-title":"Diosgenin as a substitute for cholesterol alleviates NAFLD by affecting CYP7A1 and NPC1L1-related pathway","volume":"125","author":"Yan","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0074","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13568-024-01756-7","article-title":"Seabuckthorn polysaccharides mitigate hepatic steatosis by modulating the nrf-2\/HO-1 pathway and gut microbiota","volume":"14","author":"Yan","year":"2024","journal-title":"AMB Express."},{"key":"10.1016\/j.phymed.2026.157987_bib0075","article-title":"Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.phymed.2026.157987_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/foods12132492","article-title":"Ginsenoside Rh4 improves hepatic lipid metabolism and inflammation in a model of NAFLD by targeting the gut liver axis and modulating the FXR signaling pathway","volume":"12","author":"Yang","year":"2023","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0077","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41430-020-0679-3","article-title":"The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial","volume":"75","author":"Yari","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.phymed.2026.157987_bib0078","first-page":"0904","article-title":"Microbial interactions with intestinal lipid digestion and absorption: emerging targets for metabolic disorders","volume":"8","author":"Yin","year":"2025","journal-title":"Research (Washington, D.C.)"},{"issue":"5","key":"10.1016\/j.phymed.2026.157987_bib0079","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41564-021-00880-5","article-title":"Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice","volume":"6","author":"Yoon","year":"2021","journal-title":"Nat. Microbiol."},{"issue":"4","key":"10.1016\/j.phymed.2026.157987_bib0080","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0081","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12944-025-02750-z","article-title":"The burden of NAFLD (now referred to as MASLD)-related chronic liver disease and cirrhosis from 1990 to 2021 with projections to 2036: a comparative study of global China the United States and India","volume":"24","author":"Zeng","year":"2025","journal-title":"Lipids Health Dis."},{"issue":"19","key":"10.1016\/j.phymed.2026.157987_bib0082","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1080\/10408398.2018.1517725","article-title":"A next generation probiotic, Akkermansia muciniphila","volume":"59","author":"Zhai","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.phymed.2026.157987_bib0083","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.gendis.2021.09.007","article-title":"Desulfovibrio desulfuricans aggravates atherosclerosis by enhancing intestinal permeability and endothelial TLR4\/NF-\u03baB pathway in Apoe (-\/-) mice","volume":"10","author":"Zhang","year":"2023","journal-title":"Genes Dis."},{"issue":"10","key":"10.1016\/j.phymed.2026.157987_bib0084","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12100892","article-title":"Integrated analysis of gut microbiome and lipid metabolism in mice infected with carbapenem-resistant enterobacteriaceae","volume":"12","author":"Zhang","year":"2022","journal-title":"Metabolites."},{"issue":"3","key":"10.1016\/j.phymed.2026.157987_bib0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.20517\/mrr.2025.12","article-title":"Bile salt hydrolase: a key player in gut microbiota and its implications for metabolic dysfunction-associated steatotic liver disease","volume":"4","author":"Zhao","year":"2025","journal-title":"Microbiome Res. Rep."},{"key":"10.1016\/j.phymed.2026.157987_bib0086","article-title":"Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:55:32Z","timestamp":1777593332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326002242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":86,"alternative-id":["S0944711326002242"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.157987","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isorhamnetin alleviates diet induced MASLD in mice by modulating gut microbiota and bile acid metabolism","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.157987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157987"}}